Last reviewed · How we verify

NCT06239012: SAPA

Reliability and Validity Evaluation of the BePoW Device

Completed NA Last updated 1 August 2025
What this trial tests

NA trial testing Position measurement with BePow in Position Sense Disorders in 60 participants. Completed in 3 December 2024.

Timeline
29 February 2024
Primary endpoint
3 December 2024
3 December 2024

Quick facts

Lead sponsorPôle Saint Hélier
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date29 February 2024
Primary completion3 December 2024
Estimated completion3 December 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Pôle Saint Hélier

Who can join

18 and older, any sex, with Position Sense Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical investigation is to develop a reliable and valid device to instantly measure the subject's sitting posture in a wheelchair, without using the MCPAA scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pôle Saint Hélier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06239012.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing